Skip to main content

Day: November 20, 2025

Medx Holdings Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 Expansion

Medx Posts Strong Q3 Reports Austin Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH)LazyDaze Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 ExpansionDisciplined growth, strengthened operations, and a cannabis model built for real regulation – not loopholes. Austin, Texas – [DATE]MedX Holdings, Inc. (OTC: MEDH), parent company of LazyDaze + Coffeeshop, today announced strong third-quarter results marked by significant revenue growth, a return to operating profitability, and continued expansion of its national franchise footprint. The company also outlined key operational and strategic initiatives designed to reinforce the foundation of its business ahead of major growth planned for 2026. Record Quarter, Strong FundamentalsLazyDaze reported Q3 revenue of $568,177,...

Continue reading

SAIC Schedules Third Quarter Fiscal Year 2026 Earnings Conference Call for December 4 at 10 A.M. ET

RESTON, Va., Nov. 20, 2025 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) is scheduled to issue its third quarter fiscal year 2026 results before market open on Thursday, December 4, 2025. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. Eastern time, following the issuance of the company’s earnings press release.  The conference call will be webcast simultaneously to the public through a link on the Investors Relations section of the SAIC website. The company will only provide webcast access, “dial-in” access will not be available, and a supplemental presentation will be available to the public through links provided on the website.  After the call concludes, an on-demand audio replay of the webcast can be accessed on the SAIC Investors...

Continue reading

JPMorgan Asset Management (Canada) Inc. Exchange Traded Funds 2025 Estimated Annual Reinvested Capital Gain Distributions

TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the estimated annual reinvested capital gain distributions for the below listed JPMorgan ETFs (the “Funds”). These estimates are for the annual non-cash capital gains distributions, which are typically reinvested in additional units of the respective Funds at the year-end, and do not include estimates of ongoing monthly or quarterly cash distribution amounts. The additional units will be immediately consolidated with the previously outstanding units such that the number of outstanding units following the distribution will equal the number of units outstanding prior to the distribution. Please note that these are estimated capital gains amounts only, as of October 31, 2025. As these are estimated amounts, the final capital gains distributions...

Continue reading

Tarkett_Tarkett Participation_Reopening of the public buyout offer

 Reopening of the public buyout offer followed by a squeeze-out by Tarkett Participation on Tarkett sharesThe Paris Court of Appeal has dismissed the application for annulment filed by a minority shareholder against the clearance decision issued by the Autorité des Marchés Financiers (AMF) on the public buy-out offer followed by a squeeze-out filed by Tarkett Participation on Tarkett shares. The Offer will be reopened for a period of 10 trading days from November 24, 2025 until December 5, 2025 inclusive.PARIS, FRANCE, NOVEMBER 20, 2025 On November 20, 2025, the Paris Court of Appeal has dismissed the application for annulment filed by a minority shareholder against the clearance decision issued by the Autorité des Marchés Financiers (AMF) on the public buyout offer followed by a squeeze-out (the ” Offer “)1 initiated by...

Continue reading

GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update  

Cash and cash equivalents totaled €119.0 million as of September 30, 2025 €39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and reimbursement approval of Iqirvo® (elafibranor) in three major European marketsLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its third quarter 2025 financial results1 and provided a corporate update. Cash Position As of September 30, 2025, the Company’s cash and cash equivalents amounted to €119.0 million compared with €107.5 million as of June 30, 2025, and €81.8 million as of December 31, 2024. We...

Continue reading

Aspo Plc: Share repurchase 20.11.2025

Aspo Plc  ANNOUNCEMENT  20.11.2025          Aspo Plc: Share repurchase 20.11.2025       In the Helsinki Stock Exchange         Trade date           20.11.2025  Bourse trade         Buy  Share                  ASPO  Amount             2 312 SharesAverage price/ share    6,6827 EURTotal cost            15 450,40 EUR          Aspo Plc now holds a total of 36 555 shares  including the shares repurchased on 20.11.2025       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.          On behalf of Aspo Plc         Nordea Bank Oyj              Sami Huttunen Ilari Isomäki       For more information, please contact:  Erkka...

Continue reading

MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors

MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and kills cancer cells Activates multiple immune pathways to generate potent, lasting anti-tumor activity in lung and MSS colorectal cancer modelsNEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced the publication of new preclinical data for MiNK-215, a novel, next-generation FAP-targeting, IL-15–enhanced CAR-iNKT therapy. The manuscript, titled The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunity”, is now available on Cancer Immunology Research...

Continue reading

Li Bang International Announces the Listing of Class A Ordinary Shares

JIANGYIN, China, Nov. 20, 2025 (GLOBE NEWSWIRE) — Li Bang International Corporation Inc. (“Li Bang International”) and its subsidiaries (collectively, the “Company,” “we,” “us,” “our company,” or “Li Bang”) (Nasdaq: LBGJ), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced the listing of the new Class A ordinary shares, par value US$0.0001 per share (“Class A Ordinary Shares), on the Nasdaq Capital Market in substitution for the previously listed ordinary shares, par value US$0.0001 per share (“Ordinary Shares”). Starting from the opening of trading on November 21, 2025, being the market effective date, the Class A Ordinary Shares will begin trading on the Nasdaq Capital...

Continue reading

Quadient Teams Up with Swipe Out Hunger to Support Campus Food Pantries through Automated Locker Technology

Swipe Out HungerQuadient partners with Swipe Out Hunger to support campus food pantries.Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, today announced a new collaboration with Swipe Out Hunger, a U.S. nonprofit powering the movement to end college student hunger. The partnership aims to expand access to nutritious food for students experiencing food insecurity through Quadient’s automated locker technology. Quadient is providing exclusive discounts on its Parcel Pending by Quadient automated locker solutions to Swipe Out Hunger member campuses for their food access programs, including basic needs hubs and food pantries. Quadient lockers are already used by more than 40 college and university food pantries across North America, helping to streamline food program...

Continue reading

Uppgjör Brims á þriðja ársfjórðungi 2025

Helstu atriði úr fjárhagsuppgjöri 3F 2025Vörusala var 111 m€ á fjórðungnum samanborið við 110 m€ á þriðja fjórðungi 2024 Hagnaður var 29 m€ á fjórðungnum samanborið við 19 m€ á þriðja fjórðungi 2024 EBITDA var 42 m€ og EBITDA hlutfall 37,3% Eignir hafa lækkað um 13 m€ frá áramótum og voru 983 m€ í lok tímabilsins Eigið fé þann 30. september 2025 var 505 m€ og eignfjárhlutfall 51,4%Guðmundur Kristjánsson, forstjóri: „Afkoma þriðja fjórðungs er góð og eru það tveir þættir sem skipta mestu máli. Veiðar og vinnsla á makríl gengu vel og verð á sjávarafurðum er hátt um þessar mundir. Þegar við horfum til seinustu 12 mánaða er ávöxtun eigin fjár 12%. Í september var tilkynnt um kauptilboð félagsins í allt hlutafé Lýsis hf. Með kaupunum sér Brim mikil samlegðar- og sóknarfæri bæði tengt hráefnaöflun Lýsis og fyrir Brim til að ná lengra í...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.